Delivery Order SPE2DB20D3101-SPE2DB24FRGC6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,429.48 Firm Fixed Price Delivery Order is for 4,560,941,986 units of Epinephrine 0.3 mg Auto-Inject with a completion date of May 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of 4,563,617,937 units of Epinephrine 0.3 mg auto-injectors. The $6,053.40 firm fixed-price delivery order was awarded on February 9, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of February 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,794.36 for the supply of 4,560,191,097 units of Epinephrine 0.15 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 9, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Epinephrine 0.3 mg auto-injectors to the U.S. Department of Defense Medical Supply Chain. The award, valued at $3,515.25, is a delivery order under an Indefinite Delivery Contract (IDC) the company holds with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,043,090 units of Epinephrine 0.3 mg Auto-Injectors, which are critical medical supplies for military and government healthcare programs. The contract has a ceiling value of $1,564.81 and an ultimate completion date of December 11, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,495.30 firm fixed-price delivery order is for the supply of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $7,697.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product for emergency care. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,158.48 for the supply of Epinephrine 0.3 mg auto-inject medical devices. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a ceiling value of $8,052.90 and a firm fixed price. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,263.76 firm-fixed-price delivery order is for the supply of 4,563,033,632 units of epinephrine 0.3 mg auto-injectors, with a completion date of December 8, 2023. The contract has no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRGC6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $30,660.08 for the supply of 4,564,235,925 units of Epinephrine 0.3 mg Auto-Injectors. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.7k | 4/10/24 |